Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
- Status
- COMPLETED
- Phase
- PHASE2
Dexamethasone-implant for the Treatment of RVO
- Status
- COMPLETED
- Phase
- PHASE4
Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Paclitaxel-bevacizumab in Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab/Doxorubicin/Radiation for Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Subconjunctival Bevacizumab and Recurrent Pterygium
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab Beyond Progression (BBP)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable
- Status
- COMPLETED
- Phase
- PHASE2
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management
- Status
- COMPLETED
- Phase
- PHASE4
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE2
Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2